Profil
Jane Buus Laursen is currently Director at Stayble Therapeutics AB since 2018.
Formerly, Corporate VP-Global Business Development at Novo Nordisk A. Education includes doctorates from the University of Kansas and the Technical University of Denmark.
Postes actifs de Jane Buus Laursen
| Sociétés | Poste | Début |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2018 |
| CAMURUS AB | Corporate Officer/Principal | 23/03/2026 |
Anciens postes connus de Jane Buus Laursen
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formation de Jane Buus Laursen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
















